Ironwood pharmaceuticals gmbh
WebIronwood Pharmaceuticals has raised a total of $634M in funding over 10 rounds. Their latest funding was raised on Sep 26, 2016 from a Post-IPO Debt round. Ironwood Pharmaceuticals is registered under the ticker NASDAQ:IRWD . Their stock opened with $11.25 in its Feb 12, 2010 IPO. Ironwood Pharmaceuticals is funded by 5 investors. WebMar 9, 2024 · Ironwood Pharmaceuticals Inc (A)'s market capitalization is $1.69 B by 154.16 M shares outstanding. Is Ironwood Pharmaceuticals stock a Buy, Sell or Hold? Ironwood Pharmaceuticals stock...
Ironwood pharmaceuticals gmbh
Did you know?
WebNov 4, 2024 · Ironwood Pharmaceuticals (Nasdaq: IRWD) is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine … WebIronwood Pharmaceuticals IncCountry. United States of America. Address. 100 Summer Street, Suite 2300, Boston, Massachusetts, 02110. Phone Number. 1 617 6217722. …
WebIRONWOOD PHARMACEUTICALS INC has an Investment Rating of HOLD; a target price of $11.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a... WebIronwood Pharmaceuticals. Glassdoor gives you an inside look at what it's like to work at Ironwood Pharmaceuticals, including salaries, reviews, office photos, and more. This is …
WebSep 18, 2024 · Ironwood was founded in 1998 and is headquartered in Cambridge, Mass. For more information, please visit our website at www.ironwoodpharma.com or www.twitter.com/ironwoodpharma ; information that may be important to investors will be routinely posted in both these locations. Ironwood Forward Looking Statements WebDec 23, 2024 · Ironwood Pharmaceuticals Posts Flat Q4 Adjusted Profit, Revenue Drops; Sets Fiscal 2024.. Transcript : Ironwood Pharmaceuticals, Inc., Q4 2024 Earnings Call, Feb 16, 2.. Analyst Recommendations on IRONWOOD PHARMACEUTICALS, INC. Wells Fargo Adjusts Ironwood Pharmaceuticals' Price Target to $13 from $12, Maintains E..
Web2 days ago · DelveInsight’s “Gastroparesis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Gastroparesis, historical and forecasted epidemiology as well as the Gastroparesis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.. To Know in detail … inclination\\u0027s s1WebIronwood Pharmaceuticals Q4 and Full Year 2024 Investor Update Conference Call. Listen to webcast. Presentation. January 11, 2024 09:00 AM PT / 12:00 PM ET. inclination\\u0027s s2WebIronwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI … Mr. Emany has served as our chief financial officer since December 2024. Prior to … The Boston Globe named Ironwood Pharmaceuticals a Top Place to Work for … Our in-market product, LINZESS® (linaclotide), discovered in-house, is the … Ironwood Pharmaceuticals wants to make our careers website accessible to all … In November 2024 into a collaboration and license option agreement with COUR … Ironwood Pharmaceuticals. 100 Summer Street Suite 2300 Boston MA 02110. … Ironwood Pharmaceuticals is a patient-focused, biopharmaceutical company on … By providing your email address below, you are providing consent to Ironwood … One in five Americans suffer from GI diseases, resulting in millions of hospital … inboxdollars real or fakeWebGlassdoor gives you an inside look at what it's like to work at Ironwood Pharmaceuticals, including salaries, reviews, office photos, and more. This is the Ironwood Pharmaceuticals company profile. All content is posted anonymously by employees working at Ironwood Pharmaceuticals. Argentina. Australia. inclination\\u0027s s5WebMar 9, 2024 · On Wednesday 03/08/2024 the closing price of the Ironwood Pharmaceuticals Inc (A) share was $10.74 on NAS. Compared to the opening price on Wednesday … inboxdollars reddit 2022WebMar 26, 2024 · Ironwood Pharmaceuticals (NASDAQ: IRWD) is a GI healthcare company dedicated to advancing the treatment of GI diseases and redefining the standard of care for millions of GI patients. We ... inclination\\u0027s s4WebApr 11, 2024 · finance.yahoo.com - February 10 at 10:29 AM. Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call. finance.yahoo.com - February 2 at 6:17 PM. Ironwood Pharmaceuticals (NASDAQ:IRWD) shareholders are up 3.7% this past week, but still in the red over the last five years. inclination\\u0027s s8